Detalhe da pesquisa
1.
Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancer.
Acta Oncol
; 60(2): 157-164, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33259244
2.
Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study.
Breast Cancer Res Treat
; 172(2): 391-400, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30099635
3.
Loco-regional morbidity after breast conservation and axillary lymph node dissection for early breast cancer with or without regional nodes radiotherapy, perspectives in modern breast cancer treatment: the Skagen Trial 1 is active.
Acta Oncol
; 56(5): 713-718, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28105873
4.
Efficacy and toxicity of eribulin treatment in metastatic breast cancer patients.
Acta Oncol
; 58(1): 119-121, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30101626
5.
Prediction of fulvestrant efficacy in patients with advanced breast cancer: retrospective-prospective evaluation of the predictive potential of a multigene expression assay.
Breast Cancer
; 27(2): 266-276, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31654283
6.
Treatment with eribulin (halaven) in heavily pre-treated patients with metastatic breast cancer.
Acta Oncol
; 53(9): 1275-7, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24844919